TB-500 Side Effects: Incidence Rates Across Trials
FDA found no human trials of TB-500, so no incidence rates exist. Here is what its adverse-event searches and related thymosin beta-4 trials show.
TB-500: Side Effects
3 source-based articles maintained by the HealthRX.com Editorial Team.
3articles
2topic areas covered
Jul 14, 2025latest review
TB-500: Side Effects library
Showing 3 of 3 clinical reviews.
TB-500 Side Effects: What Is and Isn't Known About Serious Risks
TB-500 safety review: FDA found no human studies or adverse-event reports and notes immunogenicity risk. One reaction involved a BPC-157 blend.
TB-500 Side Effects: Withdrawal and Discontinuation Syndrome
A clinical review of TB-500 (thymosin beta-4 active fragment) withdrawal and discontinuation syndrome, adverse events, and what to expect when stopping this research peptide.